Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.72
+0.13 (2.33%)
Jun 22, 2026, 4:00 PM EDT - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $18.35 million as of June 23, 2026. Its market cap has decreased by -34.39% in one year.
Market Cap
18.35M
Enterprise Value
-9.23M
1-Year Change
-34.39%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $18.35M, a decrease of -98.08%. That is a compound annual growth rate of -46.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 18.35M | -51.08% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 19.21M |
| GT Biopharma | 18.54M |
| Tempest Therapeutics | 18.21M |
| CEL-SCI | 18.18M |
| NewcelX | 17.82M |
| AEON Biopharma | 17.57M |
| Atossa Therapeutics | 17.31M |
| Lunai Bioworks | 17.14M |